Skinvisible Web Sign Up for Updates         T 702.433.7154   |   F 702.548.4748
Skinvisible - Polymer Delivery System

The Ultimate Polymer Delivery System.

Skinvisible Licensee Receives First European Approval for Hand Sanitizer

Rhei Pharmaceuticals to Launch HandSafe in Belgium

LAS VEGAS, Nevada. April 27, 2011 - Skinvisible, Inc. (SKVI: OTCQB) is pleased to announce that its licensee RHEI Pharmaceuticals NV has received marketing authorization from the Federal Agency for Medicines and Health Products in Belgium for HandSafe™, a unique chlorhexidine hand sanitizer made without alcohol. HandSafe™, referred to as DermSafe® in the US and Canada, is a unique, patent pending hand sanitizer formulated with 4% chlorhexidine gluconate and Skinvisible's patented polymer delivery system Invisicare®. HandSafe™ is made without alcohol so it will not dry the skin. It is proven to kill both bacteria and viruses for up to four hours including the viruses H1N1, H5N1 and H3N2.

Skinvisible licensed the commercial rights to its unique hand sanitizer to RHEI in October 2010 for Europe. This approval in Belgium is the catalyst to receiving authorization in most major countries in the European Union in an expedited manner. RHEI will now submit marketing applications for HandSafe™ under Europe's mutual recognition procedure which utilizes the marketing authorization already granted in Belgium.

"We are excited as RHEI's approval to market HandSafe™ in Belgium is a significant milestone. By leveraging this first marketing authorization, the filing process in the rest of Europe will be very straight-forward and simplified for RHEI, stated Terry Howlett, President and CEO of Skinvisible. Mr. Howlett added, "With hand sanitizer sales in Europe for the healthcare market alone is valued at over $1.7 billion in 2007 and growing 25% annually, we believe that RHEI is entering a very profitable market and will acquire significant market share in a short period of time."

"RHEI is pleased to have received the approval for HandSafe™ in an efficient and timely manner from the Belgium healthcare authorities. While waiting for approval, we have been working with potential distributors and have a number of exciting prospects for the distribution and marketing of HandSafe™," said Peter Vanderbruggen, Managing Director, Leeward Ventures SICAR SCA. "We look forward to the successful introduction of HandSafe™ in Belgium and making it available throughout Europe in the very near future."

NOTE: Skinvisible now trades exclusively on the new OTCQB (www.otcmarkets.com)

  Press Release Index
New Press Release Alerts:


Click here to join our mailing list.
Home    |     About us    |    Technology    |    Products    |    Investors    |    Contact Us    |    Disclaimer & Privacy    |     Sign Up for Updates
© 2008 Skinvisible Pharmaceuticals, Inc.     Note: This website is not intended for Canadian residents.